Forbion

Forbion is a leading European life sciences venture capital firm headquartered in Naarden, Netherlands, managing approximately €5 billion across multiple fund strategies covering all stages of biopharmaceutical drug development. The firm has a team of over 30 investment professionals and a track record of more than 130 investments across 11 funds, resulting in numerous approved therapies and successful public exits. Its newest funds—Forbion Growth Opportunities III (€1.2 billion) and Forbion Ventures VII (€890 million)—represent its largest capital raise to date.